SPIA
LFCR icon

Steward Partners Investment Advisory’s Lifecore Biomedical LFCR Stock Holding History

Steward Partners Investment Advisory’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Sell
34,085
-192
-0.6% -$967 ﹤0.01% 2288
2026
Q1 		$128K Buy
34,277
+62
+0.2% +$428 ﹤0.01% 2246
2025
Q4 		$280K Buy
34,215
+326
+1% +$2.41K ﹤0.01% 1749
2025
Q3 		$249K Buy
33,889
+1,128
+3% +$8.54K ﹤0.01% 1751
2025
Q2 		$266K Buy
32,761
+2,528
+8% +$17K ﹤0.01% 1614
2025
Q1 		$213K Buy
30,233
+3,049
+11% +$18.9K ﹤0.01% 1618
2024
Q4 		$202K Buy
27,184
+10,320
+61% +$65.9K ﹤0.01% 1608
2024
Q3 		$83.1K Buy
16,864
+9,088
+117% +$47.5K ﹤0.01% 1974
2024
Q2 		$39.9K Buy
7,776
+3,535
+83% +$20.9K ﹤0.01% 2212
2024
Q1 		$22.5K Buy
4,241
+2,177
+105% +$15.6K ﹤0.01% 2473
2023
Q4 		$12.8K Buy
2,064
+1,234
+149% +$8.57K ﹤0.01% 2605
2023
Q3 		$6.26K Buy
+830
New +$7.59K ﹤0.01% 2749
2019
Q4 		– Sell
-1,000
Closed -$10K – 2674
2019
Q3 		$10K Hold
1,000
– – ﹤0.01% 1989
2019
Q2 		$9K Buy
+1,000
New +$10.1K ﹤0.01% 2029
2018
Q4 		– Sell
-1,000
Closed -$14K – 1538
2018
Q3 		$14K Buy
+1,000
New +$13.8K ﹤0.01% 1730

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Steward Partners Investment Advisory's LFCR Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Lifecore Biomedical (LFCR) stake by 0.56% in Q2 2026, selling an estimated $967 and leaving 34,085 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Steward Partners Investment Advisory first reported a position in LFCR in Q3 2018 and has held it in 15 quarters since. The position peaked at $280K in Q4 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Steward Partners Investment Advisory held 34,085 shares of Lifecore Biomedical worth $179K as of Q2 2026.
  • Steward Partners Investment Advisory sold 192 Lifecore Biomedical shares in Q2 2026, an estimated $967.
  • Lifecore Biomedical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2288 holding.
  • Steward Partners Investment Advisory first reported a position in Lifecore Biomedical in Q3 2018 and has held it in 15 quarters since.
  • Steward Partners Investment Advisory's Lifecore Biomedical position peaked at $280K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.